Preparation method of pyran-substituted morpholine compound
Preparation of (R)-3-(5-chloro-3-methoxy-2-(tetrahydro-2H-pyran-4-yl)morpholine by multi-step reaction under basic or acidic conditions, and the current situation was solved There are problems of low yield and high cost in the middle method, and the target product preparation with high optical purity is achieved and the process flow is simplified.
Patent Information
- Application Number
- CN202411219472.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-02
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2044-09-02
AI Technical Summary
The existing preparation method for (R)-3-(5-chloro-3-methoxy-2-(tetrahydro-2H-pyran-4-yl)phenyl)morpholine has low yield and high cost. Problem, and chiral resolution is required to obtain a target product of high optical purity.
A new preparation method is provided, which comprises reacting compound IX with methanol in the presence of alkaline reagents, followed by compound VIII with tetrahydropyran in the presence of lanthanum chloride, lithium dichloride tetrahydrofuran, isopropylmagnesium chloride tetrahydrofuran The ketone reaction is followed by reaction in trifluoroacetic acid, followed by multi-step reaction with butyl lithium and N-Boc morpholinone, sodium borohydride, D-tartaric acid, N,N-isopropylethylamine and other reagents, and finally The target product was obtained under basic or acidic conditions.
High yield and low cost to obtain high optical purity (R)-3-(5-chloro-3-methoxy-2-(tetrahydro-2H-pyran-4-yl)phenyl)morpholine , avoids chiral splitting steps and simplifies the process flow.
Smart Images

Figure CN119060034A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a method for preparing a morpholine compound containing pyran substitution. Background Art
[0002] Hematopoietic progenitor kinase 1 (HPK1, also known as MAP4K1) is a member of the MAP4K family and a serine / threonine kinase. It is mainly expressed in immune cells and has the function of regulating immune cell function. Pyran-substituted morpholine compounds are important pharmaceutical intermediates with good in vivo metabolism data. Therefore, it is particularly important to develop a method for preparing pyran-substituted morpholine compounds.
[0003] In the currently known literature, patent WO2022237830A1 reports a class of nitrogen-containing heterocyclic compounds, among which compounds A-9, A-34, A-35, and A-38 containing a (R)-3-(5-chloro-3-methoxy-2-(tetrahydro-2H-pyran-4-yl)phenyl)morpholine fragment have good HPK1 kinase inhibitory activity, but the chirality of the fragment in the patent is obtained by chiral resolution.
[0004] Therefore, it is particularly important to develop a simple, easy and inexpensive synthetic route for (R)-3-(5-chloro-3-methoxy-2-(tetrahydro-2H-pyran-4-yl)phenyl)morpholine. Summary of the invention
[0005] The technical problem to be solved by the present invention is to overcome the defects of the existing preparation methods of (R)-3-(5-chloro-3-methoxy-2-(tetrahydro-2H-pyran-4-yl)phenyl)morpholine, that is, there are few methods for preparing (R)-3-(5-chloro-3-methoxy-2-(tetrahydro-2H-pyran-4-yl)phenyl)morpholine, high cost and low yield. The present invention provides a preparation method of (R)-3-(5-chloro-3-methoxy-2-(tetrahydro-2H-pyran-4-yl)phenyl)morpholine, which has high yield, can obtain a target product with high optical purity without chiral resolution, has low cost, is simple and easy to operate, and has good application prospects.
[0006] The present invention provides a method for preparing (R)-3-(5-chloro-3-methoxy-2-(tetrahydro-2H-pyran-4-yl)phenyl)morpholine, which comprises the following steps:
[0007] Step 1: In the presence of a basic reagent, compound IX reacts with methanol to obtain compound VIII;
[0008] ;
[0009] Step 2: In an organic solvent, in the presence of lanthanum chloride, lithium chloride tetrahydrofuran, isopropyl magnesium chloride tetrahydrofuran, compound VIII reacts with compound tetrahydropyrone to obtain compound VII;
[0010] ;
[0011] Step 3: In trifluoroacetic acid, in the presence of triethylsilane, compound VII is reacted to give compound VI;
[0012] ;
[0013] Step 4: In an organic solvent, in the presence of butyl lithium, compound VI and compound N-Boc morpholinone react to obtain compound V;
[0014] ;
[0015] Step 5: In an organic solvent, in the presence of sodium borohydride and D-tartaric acid, compound V is reacted to obtain compound IV;
[0016] ;
[0017] Step 6: In an organic solvent, in the presence of N,N-isopropylethylamine and methanesulfonic anhydride, compound IV is reacted to obtain compound III;
[0018] ;
[0019] Step 7 includes the following two options:
[0020] Solution 1 includes the following steps a and b:
[0021] Step a: In an organic solvent, in the presence of an alkaline reagent, compound III reacts to obtain compound II;
[0022] ;
[0023] Step b: In dichloromethane, in the presence of trifluoroacetic acid, compound II is reacted to give compound I;
[0024] ;
[0025] Scheme 2: In an organic solvent, in the presence of dioxane hydrochloride and aqueous sodium hydroxide solution, compound III is reacted to obtain compound I;
[0026] .
[0027] In the step 1, the organic solvent is methanol.
[0028] In the step 1, the mass ratio of compound IX to the organic solvent is a conventional mass-to-volume ratio for such reactions in the art, preferably 1 g / (1-10) mL, more preferably 1 g / 5 mL.
[0029] In the step 1, the alkaline reagent is a conventional alkaline reagent for such reactions in the art, preferably an inorganic base, more preferably sodium hydroxide.
[0030] In the step 1, the molar ratio of the alkaline reagent to the compound IX is a conventional molar ratio for such reactions in the art, preferably (1-5):1, more preferably 3:1.
[0031] In step 1, the reaction temperature is a conventional temperature for this type of reaction in the art, preferably 65-70°C.
[0032] In step 1, the progress of the reaction can be monitored by conventional monitoring methods in the art (such as TLC, HPLC or NMR). Generally, the reaction endpoint is when the reaction raw materials disappear or no longer react, or the product no longer increases. The reaction time can be 1-24 hours, such as 3-12 hours.
[0033] In the step 1, the reaction comprises the following steps: dissolving compound IX in methanol, stirring to dissolve, adding sodium hydroxide, heating, maintaining the internal temperature at 65-70°C and stirring; after the reaction is completed, cooling to 0-5°C, stirring for crystallization, filtering, washing the filter cake once with cold methanol, adding ethyl acetate and saturated brine to the filter cake, stirring for separation; washing the organic phase once with saturated brine, drying over anhydrous sodium sulfate, and spinning the ethyl acetate to obtain compound VIII.
[0034] In the step 2, the organic solvent is conventional in the art for such reactions, preferably an ether solvent, more preferably tetrahydrofuran.
[0035] In the step 2, the mass ratio of compound VIII to the organic solvent is a conventional mass-to-volume ratio for such reactions in the art, preferably 20 g / (50-150) mL, more preferably 20 g / 100 mL.
[0036] In the step 2, the molar ratio of the tetrahydropyrone to the compound VI is a conventional molar ratio for such reactions in the art, preferably 1.6:1.
[0037] In the step 2, the molar ratio of the lanthanum chloride / lithium dichloride tetrahydrofuran to the compound VIII is a conventional molar ratio for such reactions in the art, preferably 1:(5-15), more preferably 1:10.
[0038] In the step 2, the molar ratio of the isopropylmagnesium chloride tetrahydrofuran to the compound VIII is a conventional molar ratio for such reactions in the art, preferably (0.5-1.5):1, more preferably 1.1:1.
[0039] In the step 2, the reaction materials are added in the following order: compound VIII, isopropylmagnesium chloride tetrahydrofuran and lanthanum chloride. lithium dichloride tetrahydrofuran / tetrahydropyrone tetrahydrofuran solution.
[0040] In step 2, the reaction temperature is a conventional temperature for this type of reaction in the art, preferably -40-0°C, such as -30±5°C.
[0041] In step 2, the progress of the reaction can be monitored by conventional monitoring methods in the art (such as TLC, HPLC or NMR). Generally, the reaction endpoint is when the reaction raw materials disappear or no longer react, or the product no longer increases, for example, 0.5 hours.
[0042] In the step 3, the mass ratio of compound VII to the trifluoroacetic acid is a conventional mass-to-volume ratio for such reactions in the art, preferably (5-15):1, more preferably 10:1.
[0043] In the step 3, the molar ratio of triethylsilane to compound VII is a conventional molar ratio for such reactions in the art, preferably (1-5):1, more preferably 2:1.
[0044] In step 3, the reaction temperature is a conventional temperature for this type of reaction in the art, preferably (0-25)°C, more preferably 10°C-15°C.
[0045] In the step 3, the reaction is as follows: adding trifluoroacetic acid, cooling to 10°C, adding triethylsilane under stirring, adding compound VII in batches, continuing to stir, and after the reaction is completed, concentrating trifluoroacetic acid and triethylsilane, adding dichloromethane, adjusting the pH to 8-9 with a saturated sodium carbonate solution, separating the liquids, extracting the aqueous phase with dichloromethane, combining the organic phases, washing the organic phases with saturated brine, drying over anhydrous sodium sulfate, and drying by spin drying, adding n-heptane and methyl tert-butyl ether, heating to 50°C, stirring, cooling to room temperature, continuing to stir, filtering, washing the filter cake with n-heptane / MTBE, and drying the filter cake to obtain compound VI.
[0046] In step 3, the progress of the reaction can be monitored by conventional monitoring methods in the art (such as TLC, HPLC or NMR). Generally, the reaction endpoint is when the reaction raw materials disappear or no longer react, or the product no longer increases, for example, 0.5 hours.
[0047] In step 4, the organic solvent is conventional in the art for such reactions, preferably an ether solvent, more preferably tetrahydrofuran.
[0048] In step 4, the mass ratio of compound VI to the organic solvent is a conventional mass-to-volume ratio for such reactions in the art, preferably (20-50) g / L, more preferably 40 g / L.
[0049] In step 4, the molar ratio of N-Boc morpholinone to compound VI is a conventional molar ratio for such reactions in the art, preferably (0.5-1.5):1, more preferably 1.1:1.
[0050] In step 4, the molar ratio of butyl lithium to compound VI is a conventional molar ratio for such reactions in the art, preferably (0.5-1.5):1, more preferably 1.05:1.
[0051] In step 4, the reaction temperature is a conventional temperature for this type of reaction in the art, preferably -90 to -80°C.
[0052] In step 4, the reaction is as follows:
[0053] (i) adding butyl lithium to a solution of the compound VI and the organic solvent to react and obtain a reaction system A;
[0054] (ii) adding the compound N-Boc morpholinone and the solution of the organic solvent into the reaction system A to carry out the reaction; preferably, adding dropwise.
[0055] In step 4, the progress of the reaction can be monitored by conventional monitoring methods in the art (such as TLC, HPLC or NMR). Generally, the reaction endpoint is when the reaction raw materials disappear or no longer react, or the product no longer increases, for example, 0.5 hours.
[0056] In the step 5, the organic solvent is conventional in the art for such reactions, preferably an ether solvent, more preferably tetrahydrofuran.
[0057] In step 5, the mass ratio of compound V to the organic solvent is a conventional mass-to-volume ratio for such reactions in the art, preferably (10-40) g / L, more preferably 20 g / L.
[0058] In step 5, the molar ratio of sodium borohydride to compound V is a conventional molar ratio for such reactions in the art, preferably (2-6):1, more preferably 4:1.
[0059] In step 5, the molar ratio of D-tartaric acid to compound V is a conventional molar ratio for such reactions in the art, preferably (1-5):1, more preferably 3:1.
[0060] In step 5, the reaction temperature is a conventional temperature for this type of reaction in the art, preferably -20-15°C, more preferably 0°C.
[0061] In the step 5, the reaction is as follows:
[0062] (i) adding D-tartaric acid to the solution of the sodium borohydride and the organic solvent to react to obtain a reaction system A;
[0063] (ii) adding the solution of the compound V and the organic solvent into the reaction system A for reaction.
[0064] In step 5, the progress of the reaction can be monitored by conventional monitoring methods in the art (such as TLC, HPLC or NMR). Generally, the reaction endpoint is when the reaction raw materials disappear or no longer react, or the product no longer increases, for example, 16 hours.
[0065] In step 6, the organic solvent is conventional in this field for such reactions, and is preferably dichloromethane.
[0066] In step 6, the mass ratio of compound IV to the organic solvent is a conventional mass-to-volume ratio for such reactions in the art, preferably (20-60) g / L, more preferably 40 g / L.
[0067] In step 6, the molar ratio of N,N-isopropylethylamine to compound IV is a conventional molar ratio for such reactions in the art, preferably (2-6):1, more preferably 4:1.
[0068] In step 6, the molar ratio of methanesulfonic anhydride to compound IV is a conventional molar ratio for such reactions in the art, preferably (1-4):1, more preferably 2:1.
[0069] In step 6, the reaction temperature is a conventional temperature for this type of reaction in the art, preferably -15-10°C, more preferably 0°C.
[0070] In the step 6, the reaction is as follows: adding an organic solvent solution of methanesulfonic anhydride to a solution of the compound IV, N,N-isopropylethylamine and the organic solvent for reaction.
[0071] In step 6, the progress of the reaction can be monitored by conventional monitoring methods in the art (such as TLC, HPLC or NMR). Generally, the reaction endpoint is when the reaction raw materials disappear or no longer react, or the product no longer increases, for example, 2 hours.
[0072] In the step a, the organic solvent is conventional in the art for such reactions, preferably an ether solvent, more preferably tetrahydrofuran.
[0073] In the step a, the mass ratio of compound III to the organic solvent is a conventional mass-to-volume ratio for such reactions in the art, preferably (25-45) g / L, more preferably 35 g / L.
[0074] In the step a, the alkaline reagent is a conventional base for such reactions in the art, preferably an inorganic base, more preferably sodium hydrogen sulfide.
[0075] In the step a, the molar ratio of the alkaline reagent to compound III is a conventional ratio for such reactions in the art, preferably (5-15):1, more preferably 10:1.
[0076] In the step a, the reaction temperature is a conventional temperature for this type of reaction in the art, preferably -15-10°C, more preferably 0°C.
[0077] In step a, the progress of the reaction can be monitored by conventional monitoring methods in the art (such as TLC, HPLC or NMR). The reaction endpoint is generally when the reaction starting materials disappear or no longer react, or when the product no longer increases, for example, 16 hours.
[0078] In the step a, the reaction is as follows: adding compound III and tetrahydrofuran, cooling to 0°C, adding sodium hydrogen in batches, heating to room temperature and stirring for 16 hours, cooling to 0°C after the reaction, slowly adding saturated ammonium chloride solution to the reaction solution to quench, extracting twice with methyl tert-butyl ether until there is no product in the aqueous phase, combining the organic phases, washing the organic phases with saturated brine, concentrating, and eluting with a petroleum ether / ethyl acetate system to obtain compound II.
[0079] In the step b, the mass ratio of compound II to the organic solvent is a conventional mass-to-volume ratio for such reactions in the art, preferably (18-30) g / L, more preferably 24 g / L.
[0080] In the step b, the mass volume ratio of the compound II to trifluoroacetic acid is a conventional ratio for such reactions in the art, preferably (80-150) g / L, more preferably 120 g / L.
[0081] In the step b, the reaction temperature is a conventional temperature for this type of reaction in the art, preferably -15-10°C, more preferably 0°C.
[0082] In step b, the progress of the reaction can be monitored by conventional monitoring methods in the art (such as TLC, HPLC or NMR). Generally, the reaction endpoint is when the reaction raw materials disappear or no longer react, or the product no longer increases, for example, 2 hours.
[0083] In the step b, the reaction is as follows: adding compound II and dichloromethane, cooling to 0°C, slowly dropping trifluoroacetic acid, and continuing stirring for 2 hours. After the reaction is completed, concentrating to remove most of the solvent, dichloromethane is evaporated twice, and the residue is dissolved in dichloromethane. The pH is adjusted to alkaline with 5% sodium bicarbonate solution under a water bath, and the liquids are separated. The aqueous phase is extracted with dichloromethane, the organic phases are combined, washed with saturated brine, and the organic phase is dried, filtered, and concentrated to obtain compound I.
[0084] In the second scheme, the organic solvent is conventional for such reactions in the art, preferably an ether solvent or an alcohol solvent, more preferably dioxane or methanol.
[0085] In the second scheme, the mass ratio of compound III to the organic solvent is a conventional mass-to-volume ratio for such reactions in the art, preferably (50-150) g / L, more preferably 100 g / L.
[0086] In the second scheme, the mass volume ratio of the sodium hydroxide aqueous solution is the conventional ratio for such reactions in the art, preferably (150-250) g / L, more preferably 200 g / L.
[0087] In the second scheme, the mass volume ratio of compound III to the sodium hydroxide aqueous solution is a conventional ratio for such reactions in the art, preferably (150-250) g / L, more preferably 200 g / L.
[0088] In the second scheme, the reaction temperature is a conventional temperature for this type of reaction in the art, preferably -15-25°C, more preferably 0-10°C.
[0089] In the second scheme, the progress of the reaction can be monitored by conventional monitoring methods in the art (such as TLC, HPLC or NMR). The reaction endpoint is generally when the reaction raw materials disappear or no longer react, or the product no longer increases, such as 16 hours.
[0090] In the scheme 2, the reaction is as follows: add compound III and 4M dioxane hydrochloride solution, cool to 0-10°C, stir for 2 hours, after the reaction is completed, concentrate to remove dioxane hydrochloride, add methanol, cool to 0-10°C, slowly dropwise add aqueous sodium hydroxide solution, warm to room temperature and stir for 16 hours, filter, rinse the wet product with water, and dry to obtain compound I.
[0091] After the reaction is completed, a post-treatment step is further included, and the post-treatment step is a conventional post-treatment method for this type of compound in the art, such as quenching with water, quenching with acid or base, adjusting the pH of the reaction solution, extracting with an organic solvent, or concentrating under reduced pressure.
[0092] After the reaction is completed, a purification step is further included. The purification step is a conventional purification method for this type of compound in the art, such as column chromatography separation or preparative plate separation.
[0093] The present invention also provides a compound as shown in formula VIII or a salt thereof;
[0094] .
[0095] The present invention also provides a method for preparing a compound as shown in formula VIII, comprising the steps of: reacting compound IX in an organic solvent in the presence of an alkaline reagent to obtain compound VIII;
[0096] ;
[0097] Wherein, the preparation conditions of the method for preparing the compound represented by formula VIII are as described in any scheme of the present invention.
[0098] The present invention also provides a compound as shown in Formula VII or a salt thereof;
[0099] .
[0100] The present invention also provides a method for preparing a compound as shown in formula VII, comprising the steps of: reacting compound VIII with compound tetrahydropyrone in an organic solvent in the presence of lanthanum chloride, lithium dichloride tetrahydrofuran, isopropyl magnesium chloride tetrahydrofuran to obtain compound VII;
[0101] ;
[0102] Wherein, the preparation conditions of the preparation method of the compound represented by Formula VII are as described in any scheme of the present invention.
[0103] Preferably, the method for preparing the compound represented by formula VII further comprises the preparation of compound VIII; the preparation conditions of compound VIII are as described in any scheme of the present invention.
[0104] The present invention also provides a compound as shown in Formula VI or a salt thereof;
[0105] .
[0106] The present invention also provides a method for preparing a compound as shown in formula VI, comprising the steps of: reacting compound VII in trifluoroacetic acid in the presence of triethylsilane to obtain compound VI;
[0107] ;
[0108] Wherein, the preparation conditions of the method for preparing the compound represented by Formula VI are as described in any scheme of the present invention.
[0109] Preferably, the method for preparing the compound represented by formula VI further comprises the preparation of compound VII; the preparation conditions of compound VII are as described in any scheme of the present invention.
[0110] The present invention also provides a compound as shown in formula V or a salt thereof;
[0111] .
[0112] The present invention also provides a method for preparing a compound as shown in formula V, comprising the steps of: reacting compound VI and compound N-Boc morpholinone in an organic solvent in the presence of butyl lithium to obtain compound V;
[0113] ;
[0114] Wherein, the preparation conditions of the method for preparing the compound represented by formula V are as described in any scheme of the present invention.
[0115] Preferably, the method for preparing the compound represented by formula V further comprises the preparation of compound VI; the preparation conditions of compound VI are as described in any scheme of the present invention.
[0116] The present invention also provides a compound as shown in formula IV or a salt thereof;
[0117] .
[0118] The present invention also provides a method for preparing a compound as shown in formula IV, comprising the following steps: reacting compound V in an organic solvent in the presence of sodium borohydride and D-tartaric acid to obtain compound IV;
[0119] ;
[0120] Wherein, the preparation conditions of the preparation method of the compound represented by formula IV are as described in any scheme of the present invention.
[0121] Preferably, the method for preparing the compound represented by formula IV further comprises the preparation of compound V; the preparation conditions of compound V are as described in any scheme of the present invention.
[0122] The present invention also provides a compound as shown in formula III or a salt thereof;
[0123] .
[0124] The present invention also provides a method for preparing a compound as shown in formula III, comprising the steps of: reacting compound IV in an organic solvent in the presence of N,N-isopropylethylamine and methanesulfonic anhydride to obtain compound III;
[0125] ;
[0126] Wherein, the preparation conditions of the method for preparing the compound represented by formula III are as described in any scheme of the present invention.
[0127] Preferably, the method for preparing the compound represented by formula III further comprises the preparation of compound IV; the preparation conditions of compound IV are as described in any scheme of the present invention.
[0128] The present invention also provides a compound as shown in formula II or a salt thereof;
[0129] .
[0130] The present invention also provides a method for preparing a compound as shown in formula II, which comprises the following steps: in an organic solvent, in the presence of an alkaline agent, reacting compound III to cyclize to obtain compound II;
[0131] ;
[0132] Wherein, the preparation conditions of the method for preparing the compound represented by Formula II are as described in any scheme of the present invention.
[0133] Preferably, the method for preparing the compound shown in formula II also includes the preparation of compound III; the preparation conditions of compound III are as described in any scheme of the present invention.
[0134] The present invention also provides a compound as shown in formula I or a salt thereof;
[0135] .
[0136] The present invention also provides a method for preparing a compound as shown in formula I, comprising the steps of: reacting compound II in dichloromethane in the presence of trifluoroacetic acid to obtain compound I;
[0137] ;
[0138] Wherein, the preparation conditions of the method for preparing the compound as shown in Formula I are as described in any scheme of the present invention.
[0139] Preferably, the method for preparing the compound as shown in formula I also includes the preparation of compound II; the preparation conditions of compound II are as described in any scheme of the present invention.
[0140] The present invention also provides a method for preparing a compound as shown in formula I, comprising the steps of: reacting compound III in an organic solvent, sequentially in the presence of dioxane hydrochloride and an aqueous sodium hydroxide solution to obtain compound I;
[0141] ;
[0142] Wherein, the preparation conditions of the method for preparing the compound as shown in Formula I are as described in any scheme of the present invention.
[0143] Preferably, the method for preparing the compound as shown in formula I also includes the preparation of compound III; the preparation conditions of compound III are as described in any scheme of the present invention.
[0144] The reagents and raw materials used in the present invention are commercially available.
[0145] The positive progress effect of the present invention is that the method for synthesizing the compound (R)-3-(5-chloro-3-methoxy-2-(tetrahydro-2H-pyran-4-yl)phenyl)morpholine provided by the present invention has low cost, high yield, is simple and easy to operate, and has good application prospects. DETAILED DESCRIPTION
[0146] The present invention is further described below by way of examples, but the present invention is not limited to the scope of the examples. The experimental methods in the following examples without specifying specific conditions are carried out according to conventional methods and conditions, or selected according to the product specifications.
[0147]
[0148] Example 1
[0149]
[0150] Add 10 g of compound IX and 50 mL of methanol to the reaction flask, stir to dissolve, add 3.58 g of sodium hydroxide, raise the temperature, maintain the internal temperature at 65-70° C., stir and react overnight. Take samples for testing until the reaction is complete.
[0151] After the reaction, cool to 0-5°C, stir and crystallize for 1h, filter, and wash the filter cake once with 10mL cold methanol. Add 50mL ethyl acetate and 50mL saturated brine to the filter cake, stir and separate; wash the organic phase once with 50mL saturated brine and dry over anhydrous sodium sulfate. Spin dry the ethyl acetate to obtain 9.2g of compound VIII as a white solid with a purity of 99% and a yield of 89%. ( 1 H NMR,CDCl 3 , 7.34-7.33(m, 1H), 6.75(d, 1H), 3.92(s, 3H)).
[0152] Example 2
[0153]
[0154] Add 18.68 g of tetrahydropyrone to the reaction bottle, cool to 0°C, and slowly dropwise add 20.73 mL of 0.6 M lanthanum chloride-lithium chloride tetrahydrofuran solution for later use.
[0155] Add 40g of compound VIII and 200mL of tetrahydrofuran to the reaction flask, stir until dissolved, cool to -30°C, slowly drop 68.41mL of 2M isopropylmagnesium chloride tetrahydrofuran solution, and take samples to detect when the reaction is complete. Warm to -5~0°C, slowly drop the above-prepared tetrahydrofuran solution of lanthanum chloride, lithium chloride / tetrahydropyrone, continue stirring for 10 minutes, and take samples to detect when the reaction is complete.
[0156] After the reaction, the reaction solution was dropped into 100 mL of 0°C water to quench, and then the pH was adjusted to 6-7 with 20% acetic acid aqueous solution, and ethyl acetate was added for extraction twice (100 mL × 2). The organic phases were combined and washed twice with brine (100 mL × 2), dried over anhydrous sodium sulfate, and then spin-dried. 120 mL of n-heptane and 12 mL of ethyl acetate were added, stirred at room temperature for 12 hours, filtered, and the filter cake was washed once with 40 mL of n-heptane / ethyl acetate = 10 / 1. The filter cake was dried to obtain 25.8 g of compound VII as a white solid with a purity of 90.3% and a yield of 70%. ( 1 H NMR, CDCl 3, 7.344-7.339(d, 1H), 6.943- 6.938(d, 1H), 4.239(s, 1H),4.070-4.007(m, 2H), 3.928(s, 3H), 3.884-3.856(dd, 2H), 2.882-2.804(td, 2H),1.903-1.971(d, 2H)).
[0157] Example 3
[0158]
[0159] Add 213.0 g of trifluoroacetic acid to the reaction bottle, cool to 10°C, and add 14.46 g of triethylsilane under stirring. Add 20 g of compound VII in one batch. Continue stirring for 30 min, and take samples for testing until the reaction is complete.
[0160] After the reaction, most of the trifluoroacetic acid and triethylsilane were concentrated, 100 mL of dichloromethane was added, and the pH was adjusted to 8-9 with a saturated sodium carbonate solution. The liquid was separated, and the aqueous phase was extracted once with dichloromethane. The organic phases were combined, washed with saturated brine, dried over anhydrous sodium sulfate, and dried by rotation. 50 mL of n-heptane and 10 mL of methyl tert-butyl ether were added, the temperature was raised to 50°C, stirred for 4 hours, cooled to room temperature, and stirred for 2 hours. The filter cake was washed once with n-heptane / MTBE=5 / 1, and dried to obtain 23.7 g of compound VI as a white solid with a purity of 92.04% and a yield of 83%. ( 1 H NMR, CDCl 3 , 7.244-7.216(d, 1H),6.855-6.837(d, 1H), 4.111-4.071(dd, 2H), 3.861(s, 3H), 3.571-3.507(m, 3H),2.548-2.465(m, 2H), 1.498-1.462(dd, 2H)).
[0161] Example 4
[0162]
[0163] Add 20.0 g of compound VI and 250 ml of tetrahydrofuran to the reaction flask, cool to -90- -85°C, slowly drop 27.5 ml of 2.5 M butyl lithium, continue stirring for 20 min, take samples to detect when the reaction is complete, then slowly drop 14.5 g of N-Boc morpholinone in tetrahydrofuran (15 ml), continue stirring for 20 min, take samples to detect when the reaction is complete.
[0164] After the reaction, saturated ammonium chloride solution was added dropwise to the reaction solution to quench, the temperature was raised to room temperature, and the aqueous phase was extracted with ethyl acetate and water until there was no product. The organic phases were combined, washed twice with saturated brine, concentrated, and 20 ml of dichloromethane was added. The mixture was stirred at room temperature for crystallization. Solids precipitated, 100 ml of n-heptane was added dropwise, the temperature was lowered to 0°C, and stirring was continued for 30 min. Filter, and the filter cake was rinsed with a mixed solvent of dichloromethane / n-heptane = 1 / 5 to obtain 18.0 g of compound V as a white solid, with a yield of 64.3%. ( 1 H NMRCDCl 3 , 6.950-6.945 (d, 1H), 6.832-6.827 (d, 1H), 4.457 (s, 2H), 4.041-4.001(m, 2H), 3.863 (s, 3H), 3.663-3.637 (m, 2H), 3.452-3.373 (m, 4H), 2.874-2.844(m, 1H), 2.473-2.430 (m, 2H), 1.46 (s, 11H)).
[0165] Example 5
[0166]
[0167] Add 707 mg of sodium borohydride and 40 ml of tetrahydrofuran to the reaction bottle, and add 2.1 g of D-tartaric acid in batches at room temperature. A large number of bubbles will be generated. After the addition, heat to reflux and react for 4 hours. Cool to 0°C, slowly add 2.0 g of compound V in tetrahydrofuran (5 ml) solution, continue stirring for 16 hours, and take samples for detection until the reaction is complete.
[0168] After the reaction, 20 ml of methyl tert-butyl ether was added, and saturated ammonium chloride solution was slowly added dropwise at 0°C to quench. The liquid was separated, and the aqueous phase was extracted with methyl tert-butyl ether until there was no product, and the organic phase was combined. The organic phase was washed with saturated sodium bicarbonate solution and brine, respectively, concentrated, 10 ml of methyl tert-butyl ether and 5 ml of n-heptane were added, heated to 65°C to dissolve, stirred for 30 minutes, slowly cooled to room temperature, filtered, and the filter cake was washed with MTBE / n-heptane = 1 / 2 mixed solvent to obtain 1.66 g of compound IV as a white solid, with a yield of 83%, ee value of 100%, MS: m / z=430.20, [M+H] + .
[0169] Example 6
[0170]
[0171] Add 800 mg of compound IV, 20 ml of dichloromethane and 962 mg of N,N-isopropylethylamine to the reaction bottle, cool to 0°C, slowly add a dichloromethane solution of 648 mg of methanesulfonic anhydride, continue stirring for 2 h, and take samples for detection until the reaction is complete.
[0172] After the reaction was completed, water was slowly added dropwise to the reaction solution to quench. The liquid was separated, and the aqueous phase was extracted with dichloromethane until there was no product, and the organic phases were combined. The organic phase was washed with saturated brine, concentrated, and column chromatography: petroleum ether / ethyl acetate system gradient elution was performed to obtain 700 mg of compound III as a white foam, with a yield of 74%. ( 1 H NMR, CDCl 3 , 7.045-7.040 (d, 1H), 6.862-6.857 (d, 1H), 6.041-6.027 (d, 1H), 4.91 (br. s., 1H), 4.093 - 4.049 (m, 2H), 3.834 (s, 3H), 3.603-3.577 (m, 1H), 3.556-3.494 (m, 6H), 3.339-3.326(d, 2H), 2.968 (s, 3H), 1.463-1.452 (m, 11H), 1.334-1.240 (m, 2H)).
[0173] Example 7
[0174]
[0175] Add 700 mg of compound III and 20 ml of tetrahydrofuran to the reaction bottle, cool to 0°C, add 331 mg of sodium hydride in batches, heat to room temperature and stir for 16 hours, and take samples for detection until the reaction is complete.
[0176] After the reaction was completed, the temperature was lowered to 0°C, and a saturated ammonium chloride solution was slowly added to the reaction solution to quench the reaction. The solution was extracted twice with methyl tert-butyl ether until the aqueous phase was free of product, and the organic phases were combined. The organic phase was washed with saturated brine, concentrated, and eluted with a petroleum ether / ethyl acetate system to obtain 160 mg of compound II as a white solid with a yield of 27.7%. MS: m / z=412.18, [M+H] + .
[0177] Example 8
[0178]
[0179] Add 60 mg of compound II and 2.5 ml of dichloromethane to the reaction bottle, cool to 0°C, slowly add 0.5 ml of trifluoroacetic acid, continue stirring for 2 h, and take samples for detection until the reaction is complete.
[0180] After the reaction was completed, most of the solvent was removed by concentration, and dichloromethane was evaporated twice. The residue was dissolved in 10 ml of dichloromethane and the pH was adjusted to alkaline with 5% sodium bicarbonate solution under a water bath. The liquid was separated, the aqueous phase was extracted with dichloromethane again, the organic phases were combined, and washed with saturated brine. The organic phase was dried, filtered, and concentrated to obtain 25 mg of compound I as a light yellow solid with a yield of 55%. ( 1 H NMR,CDCl 3 , 7.382 (d, 1H), 6.834-6.830 (d, 1H), 4.261 (d, 1H), 4.116-4.078 (dd,2H), 3.911-3.07 (m, 1H), 3.851 (s, 3H), 3.755-3.748 (m, 2H), 3.692-3.686 (m,2H), 3.542 (t, 1H), 3.221-3.213 (td, 2H), 3.092-3.063 (m, 1H), 2.576-2.549(d, 2H), 1.456-1.298 (m, 2H)).
[0181] Example 9
[0182]
[0183] Add 200 mg of compound III and 2 ml of 4M dioxane hydrochloride solution to the reaction bottle, cool to 0-10°C, stir for 2 h, and take samples for detection until the reaction is complete.
[0184] After the reaction is completed, the dioxane hydrochloride is removed by concentration, 2 ml of methanol is added, the temperature is lowered to 0-10°C, and a solution of 200 mg of sodium hydroxide in water (1 ml) is slowly added dropwise. After the addition, the mixture is heated to room temperature and stirred for 16 hours. Samples are taken to detect the completion of the reaction. Filter, rinse the wet product with water, and dry to obtain 36 mg of compound I as a white solid with a yield of 29%. ( 1 H NMR, CDCl 3, 7.382 (d, 1H),6.834-6.830 (d, 1H), 4.261 (d, 1H), 4.116-4.078 (dd, 2H), 3.911-3.07 (m, 1H),3.851 (s, 3H), 3.755-3.748 (m, 2H), 3.692-3.686 (m, 2H), 3.542 (t, 1H),3.221-3.213 (td, 2H), 3.092-3.063 (m, 1H), 2.576-2.549 (d, 2H), 1.456-1.298(m, 2H))。
Claims
1. A method for preparing a compound as shown in formula I, characterized in that: It includes the following steps: Step 1: In the presence of a basic reagent, compound IX reacts with methanol to obtain compound VIII; ; Step 2: In an organic solvent, in the presence of lanthanum chloride, lithium chloride tetrahydrofuran, isopropyl magnesium chloride tetrahydrofuran, compound VIII reacts with compound tetrahydropyrone to obtain compound VII; ; Step 3: In trifluoroacetic acid, in the presence of triethylsilane, compound VII is reacted to give compound VI; ; Step 4: In an organic solvent, in the presence of butyl lithium, compound VI and compound N-Boc morpholinone react to obtain compound V; ; Step 5: In an organic solvent, in the presence of sodium borohydride and D-tartaric acid, compound V is reacted to obtain compound IV; ; Step 6: In an organic solvent, in the presence of N,N-isopropylethylamine and methanesulfonic anhydride, compound IV is reacted to obtain compound III; ; Step 7 includes the following two options: Solution 1 includes the following steps a and b: Step a: In an organic solvent, in the presence of an alkaline reagent, compound III reacts to obtain compound II; ; Step b: In dichloromethane, in the presence of trifluoroacetic acid, compound II is reacted to give compound I; ; Scheme 2: In an organic solvent, in the presence of dioxane hydrochloride and aqueous sodium hydroxide solution, compound III is reacted to obtain compound I; 。 2. The preparation method according to claim 1, characterized in that In step 1, one or more of the following conditions are met: (1) The mass ratio of compound IX to the organic solvent is 1 g / (1-10) mL, preferably 1 g / 5 mL; (2) The alkaline agent is an inorganic base, preferably sodium hydroxide; (3) The molar ratio of the alkaline agent to compound IX is (1-5):1, preferably 3:1; (4) The reaction temperature is 65-70°C; (5) The reaction time is 1-24 hours, for example 3-12 hours; (6) The reaction comprises the following steps: dissolving compound IX in methanol, stirring to dissolve, adding sodium hydroxide, raising the temperature, and stirring while maintaining the internal temperature at 65-70°C; after the reaction is completed, cooling to 0-5°C, stirring to crystallize, filtering, washing the filter cake once with cold methanol, adding ethyl acetate and saturated brine to the filter cake, stirring to separate the liquids; washing the organic phase once with saturated brine, drying over anhydrous sodium sulfate, and spinning the ethyl acetate to obtain compound VIII.
3. The preparation method according to claim 1, characterized in that: In step 2, one or more of the following conditions are met: (1) The organic solvent is an ether solvent, preferably tetrahydrofuran; (2) The mass ratio of compound VIII to the organic solvent is 20 g / (50-150) mL, preferably 20 g / 100 mL; (3) The molar ratio of tetrahydropyrone to compound VI is 1:(5-15), preferably 1:10; (4) The molar ratio of isopropylmagnesium chloride tetrahydrofuran to compound VIII is (0.5-1.5):1, preferably 1.1:1; (5) The reaction temperature is -40-0°C, for example -30±5°C; (6) The reaction time is 0.5 hours; (7) The reaction comprises the following steps: adding the tetrahydropyrone and the lanthanum chloride-lithium dichloride tetrahydrofuran solution to a solution of compound VIII and the organic solvent to carry out the reaction; preferably, the addition is dropwise addition.
4. The preparation method according to claim 1, characterized in that: In step 3, one or more of the following conditions are met: (1) The mass ratio of compound VII to the trifluoroacetic acid is (5-15):1, preferably 10:1; (2) The molar ratio of triethylsilane to compound VII is (1-5):1, preferably 2:1; (3) The reaction temperature is (0-25)°C, more preferably 10°C-15°C; (4) The reaction time is 0.5 hours; (5) The reaction comprises the following steps: adding trifluoroacetic acid, cooling to 10°C, adding triethylsilane under stirring, adding compound VII in batches, continuing stirring, and after the reaction is completed, concentrating trifluoroacetic acid and triethylsilane, adding dichloromethane, adjusting the pH to 8-9 with saturated sodium carbonate solution, separating the layers, extracting the aqueous phase with dichloromethane, combining the organic phases, washing the organic phases with saturated brine, drying over anhydrous sodium sulfate, and drying by rotation, adding n-heptane and methyl tert-butyl ether, heating to 50°C, stirring, cooling to room temperature, continuing stirring, filtering, washing the filter cake with n-heptane / MTBE, and drying the filter cake to obtain compound VI.
5. The preparation method according to claim 1, characterized in that: In step 4, one or more of the following conditions are met: (1) The organic solvent is an ether solvent, preferably tetrahydrofuran; (2) The mass ratio of compound VI to the organic solvent is (20-50) g / L, preferably 40 g / L; (3) The molar ratio of N-Boc morpholinone to compound VI is (0.5-1.5):1, preferably 1.1:1; (4) The molar ratio of butyl lithium to compound VI is (0.5-1.5):1, preferably 1.05:1; (5) The reaction temperature is -90 - -80°C; (6) The reaction time is 0.5 hours; (7) The reaction is as follows: (i) adding butyl lithium to a solution of the compound VI and the organic solvent to react and obtain a reaction system A; (ii) adding the compound N-Boc morpholinone and the solution of the organic solvent into the reaction system A to carry out the reaction; preferably, adding dropwise.
6. The preparation method according to claim 1, characterized in that: In step 5, one or more of the following conditions are met: (1) The organic solvent is an ether solvent, preferably tetrahydrofuran; (2) The mass ratio of compound V to the organic solvent is (10-40) g / L, preferably 20 g / L; (3) The molar ratio of sodium borohydride to compound V is (2-6):1, preferably 4:1; (4) The molar ratio of D-tartaric acid to compound V is (1-5):1, preferably 3:1; (5) The reaction temperature is -20-15°C, preferably 0°C; (6) The reaction time is 16 hours; (7) The reaction is as follows: (i) adding D-tartaric acid to the solution of the sodium borohydride and the organic solvent to react to obtain a reaction system A; (ii) adding the solution of the compound V and the organic solvent into the reaction system A for reaction.
7. The preparation method according to claim 1, characterized in that: In step 6, one or more of the following conditions are met: (1) The organic solvent is dichloromethane; (2) The mass ratio of compound IV to the organic solvent is (20-60) g / L, preferably 40 g / L; (3) The molar ratio of N,N-isopropylethylamine to compound IV is (2-6):1, preferably 4:1; (4) The molar ratio of methanesulfonic anhydride to compound IV is (1-4):1, preferably 2:1; (5) The reaction temperature is -15-10°C, preferably 0°C; (6) The reaction time is 2 hours; (7) The reaction comprises the following steps: adding a solution of methanesulfonic anhydride in an organic solvent to a solution of the compound IV, N,N-isopropylethylamine and the organic solvent for reaction.
8. The preparation method according to claim 1, characterized in that: In step a, one or more of the following conditions are met: (1) The organic solvent is an ether solvent, preferably tetrahydrofuran; (2) The mass ratio of compound III to the organic solvent is (25-45) g / L, preferably 35 g / L; (3) The alkaline agent is an inorganic base, preferably sodium hydrogen; (4) The molar ratio of the alkaline agent to compound III is (5-15):1, preferably 10:1; (5) The reaction temperature is -15-10°C, preferably 0°C; (6) The reaction time is 16 hours; (7) The reaction comprises the following steps: adding compound III and tetrahydrofuran, cooling to 0°C, adding sodium hydrogen in batches, heating to room temperature and stirring for 16 hours. After the reaction is completed, cooling to 0°C, slowly adding saturated ammonium chloride solution to the reaction solution to quench, extracting twice with methyl tert-butyl ether until there is no product in the aqueous phase, combining the organic phases, washing the organic phases with saturated brine, concentrating, and eluting with a petroleum ether / ethyl acetate system to obtain compound II.
9. The preparation method according to claim 1, characterized in that: In step b, one or more of the following conditions are met: (1) The mass ratio of compound II to the organic solvent is (18-30) g / L, preferably 24 g / L; (2) The mass volume ratio of the compound II to trifluoroacetic acid is (80-150) g / L, preferably 120 g / L; (3) The reaction temperature is -15-10°C, preferably 0°C; (4) The reaction time is 2 hours; (5) The reaction comprises the following steps: adding compound II and dichloromethane, cooling to 0°C, slowly adding trifluoroacetic acid dropwise, and continuing stirring for 2 hours. After the reaction is completed, the solvent is concentrated to remove most of it, and the dichloromethane is evaporated twice. The residue is dissolved in dichloromethane, and the pH is adjusted to alkaline with 5% sodium bicarbonate solution under a water bath. The liquids are separated, and the aqueous phase is extracted with dichloromethane again. The organic phases are combined, washed with saturated brine, and the organic phases are dried, filtered, and concentrated to obtain compound I.
10. The preparation method according to claim 1, characterized in that: In the second solution, one or more of the following conditions are met: (1) The organic solvent is an ether solvent or an alcohol solvent, preferably dioxane or methanol; (2) The mass ratio of compound III to the organic solvent is (50-150) g / L, preferably 100 g / L; (3) The mass volume ratio of the sodium hydroxide aqueous solution is (150-250) g / L, preferably 200 g / L; (4) The mass volume ratio of compound III to the sodium hydroxide aqueous solution is (150-250) g / L, preferably 200 g / L; (5) The reaction temperature is -15-25°C, preferably 0-10°C; (6) The reaction time is 16 hours; (7) The reaction comprises the following steps: adding compound III and 4M 2,4-dioxane hydrochloride solution, cooling to 0-10°C, stirring for 2 hours, and after the reaction is completed, concentrating to remove 2,4-dioxane hydrochloride, adding methanol, cooling to 0-10°C, slowly adding an aqueous solution of sodium hydroxide dropwise, and heating to room temperature after addition, stirring for 16 hours, filtering, rinsing the wet product with water, and drying to obtain compound I.
Citation Information
Patent Citations
Nitrogen-containing heterocyclic compound
WO2022237830A1
Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
CN101602741A
Method for preparing chiral 3-morpholine methanol and 3-morpholine formic acid compounds
CN103880770A
Aryl and heteroaryl ether compounds as ROR gamma modulators
CN106232582A
Substituted saturated and unsaturated N-heterocyclic carboxamides and related compounds for treatment of medical conditions
CN114901652A
